Hepcidin Plays a Key Role in 6-OHDA Induced Iron Overload and Apoptotic Cell Death in a Cell Culture Model of Parkinson's Disease

Parkinson's Disease

Volumn 2016, Issue , 2016, Pages

  Xu, Qi ^a,b   Kanthasamy, Anumantha G ^a   Jin, Huajun ^a   Reddy, Manju B ^a  

^a IOWA STATE UNIVERSITY   (United States)

^b SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CARBONYL DERIVATIVE; CASPASE 3; FERROPORTIN 1; HEPCIDIN; IRON; OXIDOPAMINE; SMALL INTERFERING RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL CULTURE; CELL VIABILITY; CONTROLLED STUDY; DNA FRAGMENTATION; ENZYME ACTIVITY; IRON OVERLOAD; NERVE CELL; NERVE DEGENERATION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PROTEIN EXPRESSION; RAT;

EID: 84984685551     PISSN: None     EISSN: 20420080     Source Type: Journal    
DOI: 10.1155/2016/8684130     Document Type: Article

References (42)

1. H. Diao, X. Li, S. Hu, and Y. Liu, "Gene expression profiling combined with bioinformatics analysis identify biomarkers for Parkinson disease, " PLoS ONE, vol. 7, no. 12, Article ID e52319, 2012.
2. S. Sharma, C. S. Moon, A. Khogali et al., "Biomarkers in Parkinson's disease (recent update), " Neurochemistry International, vol. 63, no. 3, pp. 201-229, 2013.
3. O. Myhre, H. Utkilen, N. Duale, G. Brunborg, and T. Hofer, "Metal dyshomeostasis and inflammation in Alzheimer's and Parkinson's diseases: possible impact of environmental exposures, " Oxidative Medicine and Cellular Longevity, vol. 2013, Article ID 726954, 19 pages, 2013.
4. K. Wirdefeldt, H.-O. Adami, P. Cole, D. Trichopoulos, and J. Mandel, "Epidemiology and etiology of Parkinson's disease: A review of the evidence, " European Journal of Epidemiology, vol. 26, supplement 1, pp. S1-S58, 2011.
5. E. Sofic, P. Riederer, H. Heinsen et al., "Increased iron (III) and total iron content in post mortem substantia nigra of Parkinsonian brain, " Journal of Neural Transmission, vol. 74, no. 3, pp. 199-205, 1988.
6. H. Jiang, N. Song, H. Xu, S. Zhang, J. Wang, and J. Xie, "Up-regulation of divalent metal transporter 1 in 6-hydroxydopamine intoxication is IRE/IRP dependent, " Cell Research, vol. 20, no. 3, pp. 345-356, 2010.
7. Z. Lv, H. Jiang, H. Xu, N. Song, and J. Xie, "Increased iron levels correlate with the selective nigral dopaminergic neuron degeneration in Parkinson's disease, " Journal of Neural Transmission, vol. 118, no. 3, pp. 361-369, 2011.
8. S. L. Rhodes and B. Ritz, "Genetics of iron regulation and the possible role of iron in Parkinson's disease, " Neurobiology of Disease, vol. 32, no. 2, pp. 183-195, 2008.
9. R. B. Mounsey and P. Teismann, "Chelators in the treatment of iron accumulation in Parkinson's disease, " International Journal of Cell Biology, vol. 2012, Article ID 983245, 12 pages, 2012.
10. S. Oshiro, M. S. Morioka, and M. Kikuchi, "Dysregulation of iron metabolism in Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis, " Advances in Pharmacological Sciences, vol. 2011, Article ID 378278, 8 pages, 2011.
11. J. Wang and K. Pantopoulos, "Regulation of cellular iron metabolism, " Biochemical Journal, vol. 434, no. 3, pp. 365-381, 2011.
12. T. Ganz, "Hepcidin-a regular of intestinal iron absorption and iron recycling bymacrophages, " Best Practice and Research: Clinical Haematology, vol. 18, no. 2, pp. 171-182, 2005.
13. G. Millonig, I. Ganzleben, T. Peccerella et al., "Sustained submicromolarH 2O2 levels induce hepcidin via signal transducer and activator of transcription 3 (STAT3), " The Journal of Biological Chemistry, vol. 287, no. 44, pp. 37472-37482, 2012.
14. E. Nemeth, M. S. Tuttle, J. Powelson et al., "Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization, " Science, vol. 306, no. 5704, pp. 2090-2093, 2004.
15. S.-M. Wang, L.-J. Fu, X.-L. Duan et al., "Role of hepcidin in murine brain iron metabolism, " Cellular and Molecular Life Sciences, vol. 67, no. 1, pp. 123-133, 2010.
16. C. Sun, N. Song, A. Xie, J. Xie, and H. Jiang, "High hepcidin level accounts for the nigral iron accumulation in acute peripheral iron intoxication rats, " Toxicology Letters, vol. 212, no. 3, pp. 276-281, 2012.
17. Q. Xu, A. G. Kanthasamy, and M. B. Reddy, "Neuroprotective effect of the natural iron chelator, phytic acid in a cell culture model of Parkinson's disease, " Toxicology, vol. 245, no. 1-2, pp. 101-108, 2008.
18. H. Jin, A. Kanthasamy, A. Ghosh, Y. Yang, V. Anantharam, and A. G. Kanthasamy, "-synuclein negatively regulates protein kinase C expression to suppress apoptosis in dopaminergic neurons by reducing p300 histone acetyltransferase activity, " The Journal of Neuroscience, vol. 31, no. 6, pp. 2035-2051, 2011.
19. R. Gordon, V. Anantharam, A. G. Kanthasamy, and A. Kanthasamy, "Proteolytic activation of proapoptotic kinase protein kinase C by tumor necrosis factor death receptor signaling in dopaminergic neurons during neuroinflammation, " Journal of Neuroinflammation, vol. 9, article 82, 2012.
20. W. Wang, N. Song, H. Zhang, J. Xie, and J. Wang, "6-Hydroxydopamine upregulates iron regulatory protein 1 by activating certain protein kinase C isoforms in the dopaminergic MES23. 5 cell line, " International Journal of Biochemistry andCell Biology, vol. 44, no. 11, pp. 1987-1992, 2012.
21. F. Sun, A. Kanthasamy, C. Song, Y. Yang, V. Anantharam, and A. G. Kanthasamy, "Proteasome inhibitor-induced apoptosis is mediated by positive feedback amplification of PKC proteolytic activation and mitochondrial translocation, " Journal of Cellular and Molecular Medicine, vol. 12, no. 6, pp. 2467-2481, 2008.
22. Y. Ma, V. Abbate, and R. C. Hider, "Iron-sensitive fluorescent probes:monitoring intracellular iron pools, " Metallomics, vol. 7, no. 2, pp. 212-222, 2015.
23. R. R. Crichton, D. T. Dexter, and R. J. Ward, "Brain iron metabolism and its perturbation in neurological diseases, " Journal of Neural Transmission, vol. 118, no. 3, pp. 301-314, 2011.
24. P. Urrutia, P. Aguirre, A. Esparza et al., "Inflammation alters the expression of DMT1, FPN1 and hepcidin, and it causes iron accumulation in central nervous system cells, " Journal of Neurochemistry, vol. 126, no. 4, pp. 541-549, 2013.
25. H. Yang, M. Yang, H. Guan et al., "Mitochondrial ferritin in neurodegenerative diseases, " Neuroscience Research, vol. 77, no. 1-2, pp. 1-7, 2013.
26. M. Franchini, M. Montagnana, and G. Lippi, "Hepcidin and iron metabolism: from laboratory to clinical implications, " Clinica Chimica Acta, vol. 411, no. 21-22, pp. 1565-1569, 2010.
27. E. Beutler, "Hemochromatosis: genetics and pathophysiology, " Annual Review of Medicine, vol. 57, pp. 331-347, 2006.
28. T. Ganz and E. Nemeth, "The hepcidin-ferroportin system as a therapeutic target in anemias and iron overload disorders, " Hematology/The Education Program of the American Society of Hematology, vol. 2011, no. 1, pp. 538-542, 2011.
29. D. Chen, A. G. Kanthasamy, andM. B. Reddy, "EGCGprotects against 6-OHDA-induced neurotoxicity in a cell culturemodel, " Parkinson's Disease, vol. 2015, Article ID 843906, 10 pages, 2015.
30. B. Schilling, M. M. S. Bharath, R. H. Row et al., "Rapid purification and mass spectrometric characterization of mitochondrial NADH dehydrogenase (Complex I) from rodent brain and a dopaminergic neuronal cell line, " Molecular and Cellular Proteomics, vol. 4, no. 1, pp. 84-96, 2005.
31. H. Ding, C.-Z. Yan, H. Shi et al., "Hepcidin is involved in iron regulation in the ischemic brain, " PLoSONE, vol. 6, no. 9, Article ID e25324, 2011.
32. F. Du, C. Qian, Z. M. Qian et al., "Hepcidin directly inhibits transferrin receptor 1 expression in astrocytes via a cyclic AMPprotein kinase a pathway, " Glia, vol. 59, no. 6, pp. 936-945, 2011.
33. A. Schober, "Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP, " Cell and Tissue Research, vol. 318, no. 1, pp. 215-224, 2004.
34. K. L. Double, M. Maywald, M. Schmittel, P. Riederer, and M. Gerlach, "In vitro studies of ferritin iron release and neurotoxicity, " Journal of Neurochemistry, vol. 70, no. 6, pp. 2492-2499, 1998.
35. N. Song, J. Wang, H. Jiang, and J. Xie, "Ferroportin 1 but not hephaestin contributes to iron accumulation in a cell model of Parkinson's disease, " Free Radical Biology and Medicine, vol. 48, no. 2, pp. 332-341, 2010.
36. N. Song, H. Jiang, J. Wang, and J.-X. Xie, "Divalent metal transporter 1 up-regulation is involved in the 6-hydroxydopamineinduced ferrous iron influx, " Journal of Neuroscience Research, vol. 85, no. 14, pp. 3118-3126, 2007.
37. H. McGrath Jr. And P. G. Rigby, "Hepcidin: inflammation's iron curtain, " Rheumatology, vol. 43, no. 11, pp. 1323-1325, 2004.
38. R. J. Basseri, E. Nemeth, M. E. Vassilaki et al., "Hepcidin is a key mediator of anemia of inflammation in Crohn's disease, " Journal of Crohn's and Colitis, vol. 7, no. 8, pp. e286-e291, 2013.
39. E. C. Hirsch, S. Vyas, and S. Hunot, "Neuroinflammation in Parkinson's disease, " Parkinsonism and Related Disorders, vol. 18, supplement 1, pp. S210-S212, 2012.
40. K. U. Tufekci, R. Meuwissen, S. Genc, and K. Genc, "Inflammation in Parkinson's disease, " Advances in Protein Chemistry and Structural Biology, vol. 88, pp. 69-132, 2012.
41. J. Bove, D. Prou, C. Perier, and S. Przedborski, "Toxin-induced models of Parkinson's disease, " NeuroRx, vol. 2, no. 3, pp. 484-494, 2005.
42. R. Raha-Chowdhury, A. A. Raha, S. Forostyak, J.-W. Zhao, S. R. W. Stott, and A. Bomford, "Expression and cellular localization of hepcidin mRNA and protein in normal rat brain, " BMC Neuroscience, vol. 16, article 24, 2015.